Haemonetics
286 hedge funds and large institutions have $5.89B invested in Haemonetics in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 73 increasing their positions, 117 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.37% more ownership
Funds ownership: 97.52% → 97.89% (+0.37%)
14% less call options, than puts
Call options by funds: $17.6M | Put options by funds: $20.6M
38% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 117
Holders
286
Holding in Top 10
3
Calls
$17.6M
Puts
$20.6M
Top Buyers
| 1 | +$112M | |
| 2 | +$96.5M | |
| 3 | +$67.3M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$41.2M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
+$36.3M |
Top Sellers
| 1 | -$165M | |
| 2 | -$42.5M | |
| 3 | -$36.8M | |
| 4 |
Two Sigma Investments
New York
|
-$28.5M |
| 5 |
Two Sigma Advisers
New York
|
-$28.1M |